Wuhan Healthgen Biotechnology Corporation v. ExpressTec LLC
1:24-cv-00318
Overview
Parties
Defendant
InVitria, Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Ventria Bioscience Inc. Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
ExpressTec LLC Operating Company
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Plaintiff
Healthgen Biotechnology Co., Ltd. Operating Company
Represented By
8 Attorneys ListedMcCarter & English, LLP
405 N. King Street, Wilmington, DE 19801
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Wuhan Healthgen Biotechnology Corporation Operating Company
Represented By
8 Attorneys ListedMcCarter & English, LLP
405 N. King Street, Wilmington, DE 19801
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
McCarter & English, LLP
Renaissance Centre, 405 N. King Street, 8th Floor
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360ยฐ Radar 5 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| ๐บ๐ธ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → | |
| ๐จ๐ณ China | China Counterpart | View Official Patent → | |
| ๐จ๐ณ China | China Counterpart | View Official Patent → | |
| ๐บ๐ธ United States | US Continuation / Sibling | View Official Patent → |
Wuhan Healthgen Biotechnology Corporation v. ExpressTec LLC
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US9951100
Method for isolating and purifying recombinant human serum albumin from transgenic rice grain
|
Filed: 2015-04-01
Issued: 2018-04-24
|
Active (4.8 yrs remaining)
Expires: 2031-08-29
|
|
|
US10183984
Method for extracting recombinant human serum albumin from transgenic rice grain
|
Filed: 2016-01-14
Issued: 2019-01-22
|
Active (5.1 yrs remaining)
Expires: 2032-01-14
|
|
|
US10730926
Chromatographic method for isolating and purifying high-purity recombined human serum albumin
|
Filed: 2013-05-09
Issued: 2020-08-04
|
Active (6.5 yrs remaining)
+19d PTA
Expires: 2033-05-28
|
Patent Enforceability & Injunction Risk Assessment
Active Threat โ Patent is within enforceable statutory term; injunctive relief viable.
Standard Statutory Term โ No obviousness-type double patenting noted.
Under 35 U.S.C. ยง 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
15
Dispositive
9
Granted
2
Denied
0
Pending / Review
11
Motions by Category
Key Dispositive Motions & Rulings